Transmedics Group Inc (TMDX)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
68.58 -1.86 (-2.64%) 03/28/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 67.50 -1.08 (-1.57%) 17:21 ET
for Fri, Mar 28th, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
Sales | 441,540 | 241,623 | 93,459 | 30,262 | 25,639 |
Cost of Goods | 179,459 | 87,530 | 28,187 | 9,103 | 9,004 |
Gross Profit | 262,081 | 154,093 | 65,272 | 21,159 | 16,635 |
Operating Expenses | 225,044 | 183,350 | 96,896 | 60,690 | 43,023 |
Operating Income | 37,496 | -28,727 | -31,437 | -39,428 | -26,384 |
Interest Expense | 14,409 | 10,791 | 3,726 | 3,874 | 3,985 |
Other Income | 12,693 | 12,847 | -1,002 | -877 | 1,653 |
Pre-tax Income | 35,780 | -26,671 | -36,165 | -44,179 | -28,716 |
Income Tax | 316 | -1,643 | 66 | 36 | 32 |
Net Income Continuous | 35,464 | -25,028 | -36,231 | -44,215 | -28,748 |
Net Income | $35,464 | $-25,028 | $-36,231 | $-44,215 | $-28,748 |
EPS Basic Total Ops | 1.07 | -0.77 | -1.23 | -1.60 | -1.16 |
EPS Basic Continuous Ops | 1.07 | -0.77 | -1.23 | -1.60 | -1.16 |
EPS Diluted Total Ops | 1.01 | -0.77 | -1.23 | -1.60 | -1.16 |
EPS Diluted Continuous Ops | 1.01 | -0.77 | -1.23 | -1.60 | -1.16 |
EPS Diluted Before Non-Recurring Items | 1.01 | -0.11 | -1.23 | -1.60 | -1.16 |
EBITDA(a) | $57,254 | $-20,550 | $-27,959 | $-37,611 | $-24,807 |